Re:
|
ZIOPHARM Oncology, Inc. (the
“Company”)
|
|
·
|
should
the Commission or the staff, acting pursuant to delegated authority,
declare the filing effective, such declaration does not foreclose the
Commission from taking any action with respect to the
filing;
|
|
·
|
the
action of the Commission or the staff, acting pursuant to delegated
authority, in declaring the filing effective, does not relieve the Company
from its full responsibility for the adequacy and accuracy of the
disclosure in the filing; and
|
|
·
|
the
Company may not assert the declaration of effectiveness as a defense in
any proceeding initiated by the Commission or any other person under the
federal securities laws of the United
States.
|
Sincerely, | |||
ZIOPHARM ONCOLOGY, INC. | |||
|
By:
|
/s/ Richard E. Bagley | |
Richard
E. Bagley,
President, Treasurer and Chief Operating Officer |
|||